Mediators of chronic pruritus in atopic dermatitis: getting the itch out?

NK Mollanazar, PK Smith, G Yosipovitch - Clinical reviews in allergy & …, 2016 - Springer
For centuries, itch was categorized as a submodality of pain. Recent research over the last
decade has led to the realization that itch is in fact a separate and distinct, albeit closely …

Atopic dermatitis epidemiology and unmet need in the United Kingdom

MJ Cork, SG Danby, GS Ogg - Journal of Dermatological Treatment, 2020 - Taylor & Francis
Atopic dermatitis (AD), also known as atopic eczema, is a chronic inflammatory skin
condition associated with a significant health-related and socioeconomic burden, and is …

[HTML][HTML] Immunosuppressive drugs

Y Hussain, H Khan - Encyclopedia of infection and immunity, 2022 - ncbi.nlm.nih.gov
Immunosuppressant is a class of medicines that inhibit or decrease the intensity of the
immune response in the body. Most of these medications are used to allow the body less …

Consensus conference on clinical management of pediatric atopic dermatitis

E Galli, I Neri, G Ricci, E Baldo, M Barone… - Italian journal of …, 2016 - Springer
Abstract The Italian Consensus Conference on clinical management of atopic dermatitis in
children reflects the best and most recent scientific evidence, with the aim to provide …

New and emerging therapies for pediatric atopic dermatitis

HL Nguyen, KR Anderson, MM Tollefson - Pediatric Drugs, 2019 - Springer
Atopic dermatitis (AD) is a chronic, inflammatory skin disease characterized by pruritus,
inflammatory erythematous skin lesions, and skin-barrier defect. Current mainstay …

Strategies for successful management of severe atopic dermatitis

KK Brar, NH Nicol, M Boguniewicz - The Journal of Allergy and Clinical …, 2019 - Elsevier
Patients with severe atopic dermatitis (AD) are reported to represent between 10% and 18%
of all patients with AD. However, in this subgroup of patients, quality of life is significantly …

[HTML][HTML] Azathioprine

O Mohammadi, TA Kassim - 2019 - europepmc.org
Objectives: Describe the mechanism of action of azathioprine. Identify the most common
adverse events associated with azathioprine therapy. Explain the importance of monitoring …

Medical management of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric …

WS Lee, K Arai, G Alex… - Journal of …, 2023 - Wiley Online Library
Pediatric inflammatory bowel disease (PIBD) is rising rapidly in many industrialized and
affluent areas in the Asia‐Pacific region. Current available guidelines, mainly from Europe …

[PDF][PDF] Guidelines for the management of atopic dermatitis in Singapore

YK Tay, YC Chan, NS Chandran, MSL Ho… - Ann Acad Med …, 2016 - annals.edu.sg
Introduction: Atopic dermatitis is a common, chronic pruritic condition affecting both children
and adults, which has a negative impact on the quality of life. These guidelines were …

Immunomodulation with azathioprine therapy in Rasmussen syndrome: A multimodal evaluation

S Pellegrin, T Baldeweg, S Pujar, F D'Arco… - Neurology, 2021 - AAN Enterprises
Objective To verify safety and efficacy of the corticosteroid-sparing drug azathioprine (AZA)
in Rasmussen syndrome (RS), we retrospectively analyzed a cohort of patients with RS …